CYP450 Genotype-Phenotype Concordance Using the Geneva Micrococktail in a Clinical Setting
Pharmacokinetic variability is a major source of differences in drug response and can be due to genetic variants and/or drug-drug interactions. Cytochromes P450 are among the most studied enzymes from a pharmacokinetic point of view. Their activity can be measured by phenotyping, and/or predicted by...
Saved in:
Main Authors: | Kuntheavy Ing Lorenzini (Author), Jules Desmeules (Author), Victoria Rollason (Author), Stéphane Bertin (Author), Marie Besson (Author), Youssef Daali (Author), Caroline F. Samer (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Practice of CYP450 genotyping and phenotyping in children in a real-life setting
by: Frédérique Rodieux, et al.
Published: (2023) -
Rivaroxaban-induced hemorrhage associated with ABCB1 genetic defect
by: Kuntheavy Ing Lorenzini, et al.
Published: (2016) -
Prediction of cytochromes P450 3A and 2C19 modulation by both inflammation and drug interactions using physiologically based pharmacokinetics
by: Camille Lenoir, et al.
Published: (2022) -
Influence of Inflammation on Cytochromes P450 Activity in Adults: A Systematic Review of the Literature
by: Camille Lenoir, et al.
Published: (2021) -
"Late" Withdrawal Syndrome after Carbamazepine In Utero Exposure in a CYP2C9 Slow Metabolizer Newborn
by: Caroline F. Samer, et al.
Published: (2017)